Jubilant Life Sciences rises on receiving USFDA's approval for Zolmitriptan ODT Tablets

18 Sep 2015 Evaluate

Jubilant Life Sciences is currently trading at Rs. 343.20, up by 12.65 points or 3.83% from its previous closing of Rs. 330.55 on the BSE.

The scrip opened at Rs. 334.90 and has touched a high and low of Rs. 344.80 and Rs. 332.00 respectively. So far 167308 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 373.00 on 28-Aug-2015 and a 52 week low of Rs. 116.10 on 17-Dec-2014.

Last one week high and low of the scrip stood at Rs. 346.00 and Rs. 308.15 respectively. The current market cap of the company is Rs. 5393.26 crore.

The promoters holding in the company stood at 54.02% while Institutions and Non-Institutions held 17.73% and 28.24% respectively.

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg, the generic version of Zomig-ZMT (of Astra Zeneca), which is used for acute treatment of migraine headaches in adults.

As on June 30, 2015, the company had a total of 815 filings for formulations of which 389 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients.

Jubilant Pharmova Share Price

1049.40 -24.90 (-2.32%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×